Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
37
NKTR Quote, Financials, Valuation and Earnings
Last price:
$37.60
Seasonality move
:
-2.36%
Day range:
$35.40 - $38.29
52-week range:
$6.48 - $66.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
38.85x
P/B ratio:
7.66x
Volume:
674K
Avg. volume:
892.5K
1-year change:
181.71%
Market cap:
$651.9M
Revenue:
$98.4M
EPS (TTM):
-$4.56
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $152.9M | $101.9M | $92.1M | $90.1M | $98.4M | |
| Revenue Growth (YoY) | 33.41% | -33.36% | -9.67% | -2.1% | 9.22% | |
| Cost of Revenues | $28.7M | $34.7M | $29.1M | $36.6M | $32M | |
| Gross Profit | $124.2M | $67.2M | $62.9M | $53.5M | $66.5M | |
| Gross Profit Margin | 81.21% | 65.93% | 68.35% | 59.34% | 67.54% | |
| R&D Expenses | $399.4M | $390.4M | $210.8M | $111.3M | $119.6M | |
| Selling, General & Admin | $104.7M | $122.8M | $92.3M | $77.4M | $76.8M | |
| Other Inc / (Exp) | -$45.2M | -$32.6M | -$102.6M | -$134.7M | $24.3M | |
| Operating Expenses | $504.1M | $513.3M | $303.2M | $190.9M | $199.6M | |
| Operating Income | -$379.9M | -$446.1M | -$240.2M | -$137.4M | -$133.1M | |
| Net Interest Expenses | $37.1M | $47.3M | $28.9M | $25.3M | $28.1M | |
| EBT. Incl. Unusual Items | -$443.9M | -$523.3M | -$365M | -$276.3M | -$119.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $493K | $557K | $3.2M | -$200K | -$239K | |
| Net Income to Company | -$444.4M | -$523.8M | -$368.2M | -$276.1M | -$119M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$444.4M | -$523.8M | -$368.2M | -$276.1M | -$119M | |
| Basic EPS (Cont. Ops) | -$2.49 | -$2.86 | -$1.97 | -$1.45 | -$8.68 | |
| Diluted EPS (Cont. Ops) | -$2.49 | -$2.86 | -$1.97 | -$1.45 | -$8.68 | |
| Weighted Average Basic Share | $178.6M | $183.3M | $187.1M | $190M | $13.7M | |
| Weighted Average Diluted Share | $178.6M | $183.3M | $187.1M | $190M | $13.7M | |
| EBITDA | -$367.4M | -$433.1M | -$228M | -$129.6M | -$128.7M | |
| EBIT | -$379.9M | -$446.1M | -$240.2M | -$137.4M | -$133.1M | |
| Revenue (Reported) | $152.9M | $101.9M | $92.1M | $90.1M | $98.4M | |
| Operating Income (Reported) | -$379.9M | -$446.1M | -$240.2M | -$137.4M | -$133.1M | |
| Operating Income (Adjusted) | -$379.9M | -$446.1M | -$240.2M | -$137.4M | -$133.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $24.9M | $23.6M | $24.1M | $24.1M | $11.8M | |
| Revenue Growth (YoY) | -17.02% | -5.2% | 2.2% | -0.08% | -51.13% | |
| Cost of Revenues | $5.3M | $5M | $12.4M | $4.4M | $196K | |
| Gross Profit | $19.6M | $18.7M | $11.7M | $19.7M | $11.6M | |
| Gross Profit Margin | 78.69% | 78.96% | 48.51% | 81.62% | 98.34% | |
| R&D Expenses | $103.7M | $33.6M | $24.1M | $35M | $27.3M | |
| Selling, General & Admin | $29.5M | $22.5M | $21.1M | $19M | $16.1M | |
| Other Inc / (Exp) | -$3.3M | -$16.8M | -$11.7M | -$166K | -- | |
| Operating Expenses | $133.2M | $56.1M | $45.2M | $54M | $43.1M | |
| Operating Income | -$113.6M | -$37.5M | -$33.5M | -$34.3M | -$31.5M | |
| Net Interest Expenses | $12.8M | $7M | $5.9M | $6M | $6M | |
| EBT. Incl. Unusual Items | -$129.6M | -$59.2M | -$45.9M | -$37M | -$35M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $112K | -$155K | -$61K | $9K | -$33K | |
| Net Income to Company | -$129.7M | -$59M | -$45.8M | -$37.1M | -$35.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$129.7M | -$59M | -$45.8M | -$37.1M | -$35.5M | |
| Basic EPS (Cont. Ops) | -$0.70 | -$0.31 | -$0.24 | -$0.18 | -$1.87 | |
| Diluted EPS (Cont. Ops) | -$0.70 | -$0.31 | -$0.24 | -$0.18 | -$1.87 | |
| Weighted Average Basic Share | $184.1M | $187.6M | $190.4M | $209.2M | $18.9M | |
| Weighted Average Diluted Share | $184.1M | $187.6M | $190.4M | $209.2M | $18.9M | |
| EBITDA | -$110M | -$34.8M | -$31.8M | -$33.3M | -$31.3M | |
| EBIT | -$113.6M | -$37.5M | -$33.5M | -$34.3M | -$31.5M | |
| Revenue (Reported) | $24.9M | $23.6M | $24.1M | $24.1M | $11.8M | |
| Operating Income (Reported) | -$113.6M | -$37.5M | -$33.5M | -$34.3M | -$31.5M | |
| Operating Income (Adjusted) | -$113.6M | -$37.5M | -$33.5M | -$34.3M | -$31.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $100.4M | $95M | $88.3M | $93.1M | $62.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $23.1M | $21.6M | $32.7M | $30M | $8.8M | |
| Gross Profit | $77.3M | $73.5M | $55.5M | $63.1M | $53.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $403.4M | $283.2M | $119M | $122.1M | $116.4M | |
| Selling, General & Admin | $117.8M | $102.5M | $82M | $76.9M | $74.6M | |
| Other Inc / (Exp) | -$7.6M | -$115.9M | -$137.2M | -$23.8M | -- | |
| Operating Expenses | $521.2M | $385.7M | $201M | $199M | $190.1M | |
| Operating Income | -$443.9M | -$312.3M | -$145.5M | -$135.9M | -$136.4M | |
| Net Interest Expenses | $47.4M | $29.8M | $25.7M | $24.8M | $26.6M | |
| EBT. Incl. Unusual Items | -$494.7M | -$454.1M | -$290.7M | -$168.3M | -$113.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $689K | $67K | $3M | -$9K | -$428K | |
| Net Income to Company | -$495.4M | -$454.2M | -$293.7M | -$168.3M | -$120.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$495.4M | -$454.2M | -$293.7M | -$168.3M | -$120.7M | |
| Basic EPS (Cont. Ops) | -$2.72 | -$2.44 | -$1.55 | -$0.84 | -$4.55 | |
| Diluted EPS (Cont. Ops) | -$2.72 | -$2.44 | -$1.55 | -$0.84 | -$4.56 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$430M | -$300.1M | -$136.9M | -$130.2M | -$135.2M | |
| EBIT | -$443.9M | -$312.3M | -$145.5M | -$135.9M | -$136.4M | |
| Revenue (Reported) | $100.4M | $95M | $88.3M | $93.1M | $62.6M | |
| Operating Income (Reported) | -$443.9M | -$312.3M | -$145.5M | -$135.9M | -$136.4M | |
| Operating Income (Adjusted) | -$443.9M | -$312.3M | -$145.5M | -$135.9M | -$136.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $76.9M | $70M | $66.2M | $69.3M | $33.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $18.7M | $15.4M | $26.5M | $22.7M | $836K | |
| Gross Profit | $58.2M | $54.6M | $39.8M | $46.5M | $32.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $300.7M | $183.6M | $84.2M | $92.2M | $87.6M | |
| Selling, General & Admin | $90.7M | $70.4M | $60.1M | $59.6M | $57.5M | |
| Other Inc / (Exp) | -$7.6M | -$90.9M | -$125.5M | -$14.6M | -$90K | |
| Operating Expenses | $391.4M | $254M | $144.3M | $151.8M | $144.3M | |
| Operating Income | -$333.2M | -$199.3M | -$104.6M | -$105.2M | -$111.7M | |
| Net Interest Expenses | $39.2M | $21.7M | $18.5M | $18M | $16.4M | |
| EBT. Incl. Unusual Items | -$377.6M | -$308.4M | -$234.1M | -$126.2M | -$120.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $561K | $71K | -$171K | $20K | -$169K | |
| Net Income to Company | -$378.2M | -$308.5M | -$234M | -$126.2M | -$128M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$378.2M | -$308.5M | -$234M | -$126.2M | -$128M | |
| Basic EPS (Cont. Ops) | -$2.07 | -$1.65 | -$1.24 | -$0.62 | -$5.07 | |
| Diluted EPS (Cont. Ops) | -$2.07 | -$1.65 | -$1.24 | -$0.62 | -$5.07 | |
| Weighted Average Basic Share | $548.2M | $560.3M | $568.9M | $612.8M | $244M | |
| Weighted Average Diluted Share | $548.2M | $560.3M | $568.9M | $612.8M | $244M | |
| EBITDA | -$322.5M | -$189.5M | -$98.4M | -$101.2M | -$110.8M | |
| EBIT | -$333.2M | -$199.3M | -$104.6M | -$105.2M | -$111.7M | |
| Revenue (Reported) | $76.9M | $70M | $66.2M | $69.3M | $33.4M | |
| Operating Income (Reported) | -$333.2M | -$199.3M | -$104.6M | -$105.2M | -$111.7M | |
| Operating Income (Adjusted) | -$333.2M | -$199.3M | -$104.6M | -$105.2M | -$111.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1B | $734M | $505M | $303.6M | $255.2M | |
| Short Term Investments | $862.9M | $708.7M | $416.8M | $268.3M | $211M | |
| Accounts Receivable, Net | $38.9M | $22.5M | $6M | $1.2M | -- | |
| Inventory | $19.2M | $15.8M | $19.2M | $16.1M | -- | |
| Prepaid Expenses | -- | -- | -- | $8.7M | $4.5M | |
| Other Current Assets | $21.9M | $23.3M | -- | -- | -- | |
| Total Current Assets | $1.1B | $795.6M | $546M | $330.7M | $261.3M | |
| Property Plant And Equipment | $186.1M | $177.5M | $85.9M | $36.9M | $11.8M | |
| Long-Term Investments | $136.7M | $64.8M | -- | $25.8M | $26.1M | |
| Goodwill | $76.5M | $76.5M | $76.5M | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $1.5M | $2.7M | $2.2M | $4.6M | $4.6M | |
| Total Assets | $1.5B | $1.1B | $710.6M | $398M | $303.9M | |
| Accounts Payable | $22.1M | $9.7M | $13M | $9.8M | $11.6M | |
| Accrued Expenses | $65.2M | $42.3M | $27M | $16.6M | $24.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $13.9M | $17.4M | $18.7M | $19.3M | $19.9M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $115.8M | $85.2M | $68.2M | $51.3M | $61.4M | |
| Long-Term Debt | $306.4M | $273.9M | $239.3M | $211.1M | $174.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $461.5M | $437.7M | $344M | $267M | $243.1M | |
| Common Stock | $18K | $19K | $19K | $19K | $19K | |
| Other Common Equity Adj | -$2.3M | -$4.2M | -$6.9M | $80K | $61K | |
| Common Equity | $1.1B | $679.5M | $366.6M | $131M | $60.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.1B | $679.5M | $366.6M | $131M | $60.7M | |
| Total Liabilities and Equity | $1.5B | $1.1B | $710.6M | $398M | $303.9M | |
| Cash and Short Terms | $1.1B | $734M | $505M | $303.6M | $255.2M | |
| Total Debt | $306.4M | $273.9M | $239.3M | $211.1M | $174.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $921.1M | $546.4M | $372.7M | $244.5M | $270.2M | |
| Short Term Investments | $867.1M | $440.6M | $307.7M | $214.4M | -- | |
| Accounts Receivable, Net | $29M | $11.5M | $2.2M | -- | -- | |
| Inventory | $15.3M | $19.1M | $15.1M | -- | -- | |
| Prepaid Expenses | -- | -- | $7.8M | $6.8M | $9.9M | |
| Other Current Assets | $20.7M | $22.5M | -- | -- | -- | |
| Total Current Assets | $986.1M | $599.5M | $399M | $286.5M | $281.4M | |
| Property Plant And Equipment | $178.5M | $102.7M | $38.7M | $12.4M | $10M | |
| Long-Term Investments | $34.2M | -- | -- | $4.5M | $4.8M | |
| Goodwill | $76.5M | $76.5M | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $1.8M | $2.3M | $4.5M | $4.5M | -- | |
| Total Assets | $1.3B | $781M | $442.2M | $308M | $301.3M | |
| Accounts Payable | $23.7M | $5.3M | $3.3M | $8.6M | $15.6M | |
| Accrued Expenses | $65.7M | $35.8M | $18.3M | $25.4M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $17.7M | $18.5M | $19.1M | $21.5M | -- | |
| Other Current Liabilities | -- | -- | -- | $5.1M | -- | |
| Total Current Liabilities | $140M | $84M | $52.1M | $67.6M | $66.3M | |
| Long-Term Debt | $310.5M | $281.7M | $225.8M | $184.6M | $144.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $475.7M | $368.8M | $282.9M | $259.1M | $216.3M | |
| Common Stock | $18K | $19K | $19K | $19K | $2K | |
| Other Common Equity Adj | -$3.6M | -$8.2M | -$6.4M | $355K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $801.5M | $412.2M | $159.4M | $48.9M | $85.1M | |
| Total Liabilities and Equity | $1.3B | $781M | $442.2M | $308M | $301.3M | |
| Cash and Short Terms | $921.1M | $546.4M | $372.7M | $244.5M | $270.2M | |
| Total Debt | $310.5M | $281.7M | $225.8M | $184.6M | $144.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$444.4M | -$523.8M | -$368.2M | -$276.1M | -$119M | |
| Depreciation & Amoritzation | $14.2M | $14.1M | $13M | $7.8M | $4.4M | |
| Stock-Based Compensation | $94.3M | $94.7M | $57.3M | $33.4M | $21.6M | |
| Change in Accounts Receivable | $1.9M | $12.4M | $16.5M | $4.8M | -$3M | |
| Change in Inventories | -$2.6M | -$509K | -$3.4M | $699K | $497K | |
| Cash From Operations | -$313.3M | -$412.7M | -$304M | -$192.6M | -$175.7M | |
| Capital Expenditures | $7.3M | $15M | $5.7M | $865K | $1.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $496.2M | $202.8M | $365.8M | $139.6M | $142.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$250M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $3M | |
| Other Financing Activities | $146.3M | $3M | $750K | -- | $15M | |
| Cash From Financing | -$80.4M | $36.2M | $1.5M | $30K | $42.1M | |
| Beginning Cash (CF) | $189.3M | $14.3M | $66.8M | $20.2M | $28.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $102.6M | -$173.7M | $63M | -$53M | $9M | |
| Ending Cash (CF) | $291.9M | -$159.6M | $129.5M | -$32.7M | $37.2M | |
| Levered Free Cash Flow | -$320.5M | -$427.6M | -$309.7M | -$193.5M | -$177.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$129.7M | -$59M | -$45.8M | -$37.1M | -$35.5M | |
| Depreciation & Amoritzation | $3.6M | $2.7M | $1.7M | $993K | $196K | |
| Stock-Based Compensation | $24.7M | $12.5M | $8.1M | $5.4M | $3.1M | |
| Change in Accounts Receivable | -$123K | -$1.5M | -$869K | -$850K | -- | |
| Change in Inventories | -$714K | -$2.1M | $1.1M | $123K | -- | |
| Cash From Operations | -$101.1M | -$82.9M | -$42.1M | -$43.9M | -$48.8M | |
| Capital Expenditures | $2.9M | $181K | $33K | $666K | $114K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$830K | $111.4M | $56.4M | $46.1M | -$94.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $750K | -- | -- | -- | -- | |
| Cash From Financing | $3.7M | -- | -- | $13K | $141.7M | |
| Beginning Cash (CF) | $54M | $90M | $49.7M | $16.1M | $16.3M | |
| Foreign Exchange Rate Adjustment | -$25K | -$295K | -$98K | -$28K | $1K | |
| Additions / Reductions | -$98.3M | $28.2M | $14.2M | $2.2M | -$2M | |
| Ending Cash (CF) | -$44.3M | $117.9M | $63.8M | $18.2M | $14.4M | |
| Levered Free Cash Flow | -$104.1M | -$83.1M | -$42.2M | -$44.6M | -$48.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$495.4M | -$454.2M | -$293.7M | -$168.3M | -$120.7M | |
| Depreciation & Amoritzation | $14M | $13.3M | $9.3M | $5.7M | $1.2M | |
| Stock-Based Compensation | $94.3M | $67M | $38.9M | $24.1M | $15.3M | |
| Change in Accounts Receivable | $17.9M | $13.5M | $9.3M | $158K | -$2.2M | |
| Change in Inventories | -$2.4M | -$3.7M | -$517K | $263K | $1.3M | |
| Cash From Operations | -$359.8M | -$397.8M | -$203.3M | -$176.6M | -$189.7M | |
| Capital Expenditures | $10.8M | $11.1M | $1.1M | $1.2M | $612K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $175.3M | $446M | $162.2M | $99.7M | $58.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | $3M | -- | |
| Other Financing Activities | -- | $1.5M | -- | -- | -- | |
| Cash From Financing | $182.7M | $4M | $121K | $42M | $142M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.8M | $51.7M | -$40.8M | -$34.8M | $10.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$370.6M | -$408.9M | -$204.4M | -$177.8M | -$190.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$378.2M | -$308.5M | -$234M | -$126.2M | -$128M | |
| Depreciation & Amoritzation | $10.7M | $9.8M | $6.2M | $4.1M | $836K | |
| Stock-Based Compensation | $72.3M | $44.6M | $26.1M | $16.8M | $10.5M | |
| Change in Accounts Receivable | $9.9M | $11M | $3.8M | -$841K | -- | |
| Change in Inventories | -$38K | -$3.3M | -$372K | -$808K | -- | |
| Cash From Operations | -$261.1M | -$246.3M | -$145.6M | -$129.5M | -$143.6M | |
| Capital Expenditures | $9.1M | $5.2M | $628K | $1M | $153K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $82.6M | $325.8M | $122.2M | $82.4M | -$1.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | $3M | -- | |
| Other Financing Activities | $2.3M | $750K | -- | $15M | -- | |
| Cash From Financing | $33.7M | $1.4M | $18K | $42M | $141.9M | |
| Beginning Cash (CF) | $210M | $215.1M | $162.4M | $64.7M | $63.2M | |
| Foreign Exchange Rate Adjustment | -$82K | -$382K | $54K | -$37K | $6K | |
| Additions / Reductions | -$144.9M | $80.5M | -$23.3M | -$5.2M | -$3.2M | |
| Ending Cash (CF) | $65M | $295.3M | $139.2M | $59.5M | $60M | |
| Levered Free Cash Flow | -$270.2M | -$251.5M | -$146.2M | -$130.5M | -$143.7M | |
Get NKTR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NKTR
Sector
P/E ratio
--
23.89x
PEG ratio
-0.02x
-0.01x
P/B ratio
7.66x
1.81x
Price / LTM sales
38.85x
1.59x
Growth Metrics
NKTR
Sector
Revenue growth
-51.13%
4.35%
Earnings growth
-958.61%
9.8%
Revenue (5-year growth)
-3%
6.41%
Earnings forecast
-$2.90
-$0.18
Profitability
NKTR
Sector
Profitability FY 2024
$66.5M
$3.2M
Return on invested capital
-54.14%
-32.76%
Return on assets
-43.84%
-29.32%
Return on equity
-327.67%
-38.6%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Mar
11
Estimated Next Earnings Date
Feb
5
Balance Sheet
NKTR
Sector
Total cash
$270.2M
$25.4M
Short term investments
$211M
$25.1M
Total assets
$303.9M
$74.7M
Long term debt
$144.9M
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
